Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Clinical trial NCT05687123 · RECRUITING

Trial details

NCT number: NCT05687123
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Neuroendocrine Tumor Pancreatic Neoplasm Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Stage IV Pancreatic Neuroendocrine Tumor AJCC v8 Unresectable Pancreatic Neuroendocrine Tumor

Start date: 2024-08-14
Primary completion: 2026-12-14
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.